Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel mometasone furoate nasal spray vs Nasonex vs vehicle in allergic rhinitis
2013-000654-22Phase 3Terminated
- Sponsor
- Dermapharm
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone in allergic rhinitis (AR) (3 arms), sponsored by Dermapharm. Started Apr 2013; status: terminated.
02
Drugs
mometasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2013-000654-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000654-22.